European cleantech feels the pinch — looks to distinguish itself from U.S.
European cleantech is finally feeling the funding crunch. Market analysts at the Cleantech Group released a report today showing that investment in the sector during the first quarter fell to $281 million, an 11 percent drop from the previous quarter and a 31 percent drop… Continue Reading
Networking chip firm Arteris raises $7.5 million
Arteris has raised $7.5 million in a third round of financing to fund its networking chip technology.
DoCoMo capital came aboard as a new investor, joining existing investors Crescendo Ventures, TVM Capital, Ventech and Synopsis Inc. in the round, according to VentureWire.
Current customers include STMicroelectronics NV… Continue Reading
CoreOptics raises $25M for optical networking systems
CoreOptics designs 10/40/100 Gbps optical networking subsystems for tier-1 networks. Along with sales of optical fiber, the company also makes signal processing technology aimed at lowering error rates in transmission.
Founded in 2001, CoreOptics has taken over $90 million to date. The company is co-based in… Continue Reading
Life-science briefing: Tuesday, March 11, 2008
TODAY’S HEADLINES:
Affinergy gets $3M in grants for biological “linkers” (release)
Specialty pharma EUSA raises $50M, spends $23M for public biotech Cytogen (release)
Calderome takes in $12M for cancer diagnostics (peHUB)
Pulse Health raises $2M for handheld free-radical device (release)
LifeMasters takes in $15M for wellness, disease-management programs (release)
Dubai Techno… Continue Reading
Life sciences briefing: Thursday, Feb. 14, 2008
TODAY’S HEADLINES:
Arbor Surgical draws another $5.5M for heart-valve replacements (VBLS exclusive)
AstraZeneca spinout Albireo raises $27M for GI drugs (release)
Knee-implant maker MAKO Surgical slashes IPO price range (release)
eScreen takes in $8M for automated drug screening (peHUB)
GlucoLight gets undisclosed funding for glucose monitoring (release)
Oddo et al. order… Continue Reading
Life sciences briefing: Thursday, Sept. 6, 2007
Featured companies: Cyntellect, Lectus Therapeutics, NeoMatrix, Nexstim, Pearl Therapeutics, Proteon Therapeutics, SupplyScape
(UPDATED at 10am PT: See below.)
Airway-disease specialist Pearl Therapeutics raises $15.5M — Redwood City, Calif.-based Pearl Therapeutics, a drug-formulation company focused on respiratory disease, raised $15.5 million in a first funding round. Investors included New Leaf… Continue Reading
Arteris gets $8.1M more for “network on chip” design software
Arteris, a Paris, France company that offers software for designing “network on chip” semiconductors, so named because they involve communications within a chip, has raised an $8.1 million second round of financing.
The company is moving its formal headquarters to San Jose, Calif., where is has… Continue Reading
Noxxon Pharma draws $50M for aptamer drugs
Noxxon Pharma, a Berlin-based biotech, raised 37 million euros ($50 million) to help push its first aptamer-based drug candidates for kidney and eye disease into clinical trials.
The main new investors included TVM Capital, Sofinnova Partners, and Edmond de Rothschild Investment Partners.
Aptamers are short stretches of… Continue Reading